Windlas Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on May 05, 2026.
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech Limited's Board of Directors, in their meeting on May 5, 2026, approved two key changes to the board composition. First, Dr. Tarashree Singhal has been appointed as an Additional Director and Independent Woman Director for a five-year term, effective May 5, 2026, subject to shareholder approval. Dr. Singhal holds an MBBS degree from Mysore University and a PG Diploma in Ultrasonography from Annamalai University, with over 26 years of experience as a medical practitioner. Second, Mr. Srinivasan Venkataraman has completed his five-year tenure as an Independent Director and ceases to be a director with effect from the close of business hours on May 5, 2026. This is a routine board transition following the completion of an independent director's term.
The appointment of Dr. Tarashree Singhal as an Independent Woman Director enhances board diversity. The departure of Mr. Srinivasan Venkataraman after completing his term is a routine governance change with no immediate implications for shareholders.